Generate a tailored SOP for Dr. Sara Bjursten. Improve your application with a focused, well-structured draft.
Sara Bjursten is affiliated with the University of Gothenburg. Her research focuses on the effects of immune checkpoint inhibitors on cancer progression and associated adverse events. She has contributed to significant findings in the management of such therapies, specifically regarding their side effects and treatment responses in melanoma and hematologic malignancies. Her works published in reputed journals include studies on immune checkpoint inhibitor-induced arthritis, brain metastases in melanoma patients, and early markers for brain damage induced by these treatments. Through her research, she aims to improve clinical outcomes for patients undergoing these therapies by understanding the underlying mechanisms and side effects.
Administered by the Department of Political Science; focus on International Administration and Global Governance (IAGG).